title: Rapamycin in fibrotic diseases: beneficial or detrimental agent?
authors.affiliation: Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
authors.forename: Xue-Feng
authors.initials: XF
authors.lastname: Xu
authors.forename: Hua-Ping
authors.initials: HP
authors.lastname: Dai
mesh_terms: D005355:Fibrosis / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008954:Models, Biological; D020123:Sirolimus / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus